Biotech Values

[dewophile]

i googled and mrna-1083 encodes for 2 segments of spike protein versus the entire spike protein of spikevax, so a shorter length mRNA to enable lower dosing to get comparable antibody response (or higher antibody response w comparable dosing)
I assume regulators are allowing them to use neutralizing antibodies instead of clinical endpoints for this next gen covid vaccine, but I don't follow MRNA and can't confirm this